Literature DB >> 26598559

Sieve estimation in a Markov illness-death process under dual censoring.

Audrey Boruvka1, Richard J Cook2.   

Abstract

Semiparametric methods are well established for the analysis of a progressive Markov illness-death process observed up to a noninformative right censoring time. However, often the intermediate and terminal events are censored in different ways, leading to a dual censoring scheme. In such settings, unbiased estimation of the cumulative transition intensity functions cannot be achieved without some degree of smoothing. To overcome this problem, we develop a sieve maximum likelihood approach for inference on the hazard ratio. A simulation study shows that the sieve estimator offers improved finite-sample performance over common imputation-based alternatives and is robust to some forms of dependent censoring. The proposed method is illustrated using data from cancer trials.
© The Author 2015. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Cox model; Interval censoring; Method of sieves; Profile likelihood; Progression-free survival

Mesh:

Year:  2015        PMID: 26598559      PMCID: PMC5963425          DOI: 10.1093/biostatistics/kxv042

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  10 in total

1.  When you look matters: the effect of assessment schedule on progression-free survival.

Authors:  Katherine S Panageas; Leah Ben-Porat; Maura N Dickler; Paul B Chapman; Deborah Schrag
Journal:  J Natl Cancer Inst       Date:  2007-03-21       Impact factor: 13.506

2.  A simple stochastic model of recovery, relapse, death and loss of patients.

Authors:  E FIX; J NEYMAN
Journal:  Hum Biol       Date:  1951-09       Impact factor: 0.553

3.  Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.

Authors:  G N Hortobagyi; R L Theriault; L Porter; D Blayney; A Lipton; C Sinoff; H Wheeler; J F Simeone; J Seaman; R D Knight
Journal:  N Engl J Med       Date:  1996-12-12       Impact factor: 91.245

4.  Semiparametric estimation in a three-state duration-dependent Markov model from interval-censored observations with application to AIDS data.

Authors:  H Frydman
Journal:  Biometrics       Date:  1995-06       Impact factor: 2.571

5.  Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.

Authors:  L S Rosen; D Gordon; M Kaminski; A Howell; A Belch; J Mackey; J Apffelstaedt; M Hussein; R E Coleman; D J Reitsma; J J Seaman; B L Chen; Y Ambros
Journal:  Cancer J       Date:  2001 Sep-Oct       Impact factor: 3.360

6.  Joint modeling approach for semicompeting risks data with missing nonterminal event status.

Authors:  Chen Hu; Alex Tsodikov
Journal:  Lifetime Data Anal       Date:  2014-01-16       Impact factor: 1.588

7.  A penalized likelihood approach for an illness-death model with interval-censored data: application to age-specific incidence of dementia.

Authors:  Pierre Joly; Daniel Commenges; Catherine Helmer; Luc Letenneur
Journal:  Biostatistics       Date:  2002-09       Impact factor: 5.899

8.  Nonparametric estimation in a Markov "illness-death" process from interval censored observations with missing intermediate transition status.

Authors:  Halina Frydman; Michael Szarek
Journal:  Biometrics       Date:  2008-05-23       Impact factor: 2.571

9.  Statistical analysis of illness-death processes and semicompeting risks data.

Authors:  Jinfeng Xu; John D Kalbfleisch; Beechoo Tai
Journal:  Biometrics       Date:  2010-09       Impact factor: 2.571

10.  Bias in progression-free survival analysis due to intermittent assessment of progression.

Authors:  Leilei Zeng; Richard J Cook; Lan Wen; Audrey Boruvka
Journal:  Stat Med       Date:  2015-05-24       Impact factor: 2.373

  10 in total
  3 in total

1.  Bias in progression-free survival analysis due to intermittent assessment of progression.

Authors:  Leilei Zeng; Richard J Cook; Lan Wen; Audrey Boruvka
Journal:  Stat Med       Date:  2015-05-24       Impact factor: 2.373

2.  Joint modelling of colorectal cancer recurrence and death after resection using multi-state model with cured fraction.

Authors:  Behnaz Alafchi; Ghodratollah Roshanaei; Leili Tapak; Mohammad Abbasi; Hossein Mahjub
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 3.  Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review.

Authors:  Elena Olariu; Kevin K Cadwell; Elizabeth Hancock; David Trueman; Helene Chevrou-Severac
Journal:  Clinicoecon Outcomes Res       Date:  2017-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.